COVID-19 IgG/IgM Rapid Test 

Test basics

The COVID-19 Rapid Test is a qualitative diagnostic test that uses lateral flow immunochromatography technology for the specific detection of human IgG and IgM anti SARS-CoV-2 antibodies and allows the detection of such antibodies in serum, plasma or whole blood samples. This test can be used in the screening and diagnosis of SARS-CoV-2 virus infection.

Detección anticuerpos Covid

Detection of IgG / IgM anti SARS-CoV-2 antibodies

Test rápido 15 min

Quick test 15 min

Fácil uso

Easy use and interpretation of results

Validación clínica realizada en España*

Clinical validation carried out in Spain*

*Study completed at the Virgen de las Nieves Hospital (Granada). In progress, at the Hospital de Jerez.

Product use

The COVID-19 rapid test is designed to be performed by a healthcare professional and is especially indicated for:

  • Screening in the emergency triage area of ​​patients who come more than five days after the onset of symptoms
  • Confirmation of infection in patients with symptoms and suspicion of false negative in PCR
  • Identification of immunized health personnel (presence of IgG) for more than 15 days in the absence of symptoms or with negative RT-PCR
  • Obtaining epidemiological data from COVID-19
  • Identification of immunized population for clinical applications or other applications
  • Screening of the immunized population. Data that can be useful for making certain decisions

Diagnostic parameters

Diagnostic sensitivity: 91,80% – 96,40%

91,80% – 96,40%
Diagnostic specificity: 97% – 100%

97% – 100%